Background: This study examined the impact of breast cancer therapy on women's sexuality.
Introduction
Over the past ten years a great deal of effort has been expended to enhance the possibility of early diagnosis and improve the treatment of breast cancer, and problems related to the disease have been extensively investigated. It is now clear that the psychological problems most frequently observed in these patients are depression, body image-associated hypochondria and sexual dysfunction [1] [2] [3] .
The latter problem, however -especially in Italyhas not been significantly assessed because when faced with serious disease, the clinician is usually more concerned with assuring survival and restoring physical integrity. Furthermore, sexual behaviour is still considered a subject to be avoided by many doctors and their patients. There have been few epidemiological studies of the sexuality of cancer patients, although much research has been aimed at defining and quantifying sexual behaviour and disorders in oncology [4] [5] [6] [7] [8] .
Modern sexology considers sexual behaviour to be influenced by somatic and psychological factors as well as by relationships, and thus that sexual dysfunction can be studied through the complex association of these factors [9] .
In oncology patients, as in others with serious illnesses, various factors, which may also have been present before the onset of the disease, can induce sexual dysfunction. Some of these factors, such as hormonal alterations induced by chemotherapy [10] and radiotherapy, or physiological and functional disturbances related to the deterioration of physical condition, are strictly clinical. Other factors which induce disturbances in sexual behaviour, such as anxious/depressive reactions in adapting to the illness and treatment, hypochondriacal and cancerophobic reactions, regressive tendencies and loss of self esteem that accompany any illness are more psychological /psychiatric in nature [11] . Furthermore, relationship problems that emerge with the onset of cancer can be an obstacle to normal sexual behaviour [12] . Therefore, an evaluation of the ideology, mores and culture of the patient's environment is fundamental to understanding his/her situation and reactions [13] .
The doctor-patient relationship can also be malfunctional with respect to sexual dysfunction if a satisfactory level of communication has not been attained. Patients rarely ask for information about the influence the illness could have on their sexual activity, and doctors avoid the subject, assuming that the absence of questions indicates satisfactory adaptation to the situation [14] .
In such a complex situation, early research should evaluate the phenomenon; in our investigation we compared the sexual behaviour in surgically-treated women before and after breast cancer therapy.
One of the problems which most notably impedes research in sexology is the difficulty of defining and quantifying 'normal' sexual behaviour and, as a consequence, pathological behaviour.
One of the most acclaimed models in the medicalpsychiatric field is that found in the Diagnostic and Statistical Manual of Mental Problems (DSM-IV) [15] , according to which the onset of the subclass of sexual dysfunctions so-called 'disorders' is the inhibition of sexual desire or psychophysiological modifications that characterize the complete cycle of sexual response.
In most cases there are alterations both in subjective sensations of pleasure or desire, and in objective and physiological performance. However, entirely subjective alterations with no objective signs of dysfunction are not infrequent and, by contrast, inhibition of performance may occur in the absence of subjective disorders. Furthermore, sexual disorders are rarely associated with the onset of disability but are related to the pre-existent relationship with the partner.
Patients and methods
Fifty women were selected for the study during their visits to the outpatient clinic of the Division of Oncology/ Radiotherapy of S. Gerardo Hospital, Monza. All subjects had to meet the following selection criteria to be enrolled in the study: age between 20 and 65 years, surgery performed at least 12 months previously, no presently recurrent disease, affirmed sexual activity. No selection was made regarding marital status.
All of the eligible subjects selected agreed to take part in the study. This complete participation of selected patients in the study may be attributable to the fact that they were recruited in a single centre by a single investigator, the close relationship between the clinician and the patients probably conditioned their attitude toward participation in the trial.
All of the women enrolled had undergone breast surgery (42% QUART; 40% PATEY; 18% HALSTED) at least one year previously (mean 2.9 years before), and 88% had then undergone chemotherapy (CT), 46% radiotherapy (RT) and 4% hormonotherapy (HT).
A questionnaire was given to all of the women for completion without assistance (to avert any influence by a partner) which was to be returned anonymously to the 'Don Giulio Farina'association. This questionnaire (see 'Discussion' section) was compiled by the authors on the basis of concepts described in The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) to aid in assessing changes in the sexual activity and satisfaction of the subjects and in determining the presence of sexual dysfunction before and after the various therapies. Specific questions were asked about the effect of the illness on their personal relationships and their sexual behaviour and about possibilities for discussion of their problems with others.
The questionnaire has not been validated and could not be used to diagnose sexual dysfunction, and the results obtained are applicable to the sample only and cannot be generalized. Its objective was to allow patients to express their problems and to provide us with more detailed information regarding sexual problems in mastectomized women.
Results
The subjects were a median of 48 years old, S.D. 7.24 (range 31-63 years) and 96% were married with children (mean 1.6). The levels of education attained were primary school 30%, lower secondary school 26%, upper secondary school 34%, and university 2% (8% missing).
Fifty-four percent of the women were housewives, 28% company employees, 10% worked in the professions and 4% were pensioners (4% missing).
Regarding personal and sexual relationships, 98% had an important personal relationship (partner) and 96% were effectively sexually active; following the operation and various treatments 10% were no longer in the relationship and sexual relations had ceased. In view of the median age of 48 years (+/-7) the sexual problems could have been related to concomitant problems of menopause, but this is not confirmed by the correlation between age and the presence of sexual disturbances. Qualitatively, their sex life had deteriorated since before the onset of illness to the time of completion of the questionnaire: 64% considered their sex life to have been good prior to their illness, 30% fair and the remaining 6% poor; after treatment their sex life was considered good in 28%, fair in 48% and poor in 24%. However, 50% of women were content with their sex life and had sufficiently satisfying sexual relations.
Sexual dysfunctions were present in various forms: only two subjects (4%) suffered no dysfunctions. The most frequent sexual dysfunctions (Table 1) were the absence or reduction of sexual desire (48% and 64%, respectively) followed by frigidity (44%), lubrication difficulties (42%) and dyspareunia (38%). About onethird of subjects complained of inhibited female orgasm (32%), lack of interest in partner (30%), brevity of intercourse (26%) and vaginismus (18%).
The sexual dysfunctions were present before surgery in 36% (18 subjects) and of these 27% (five subjects) complained of a deterioration of the symptomatology after the various treatments.
Thirty-eight percent of the subjects indicated that they had never before suffered from sexual dysfuctions. Twenty-six percent of the dysfunctions were observed after chemotherapy, 12% after surgery and 6% after radiotherapy; none of the subjects indicated the onset of dysfunctions to have been associated with hormonotherapy (used in only 4% of subjects).
The illness and its various treatments had varying effects on the personal and sexual relationships of the subjects (Table 2) : the main causes of the the relationship problems were health worries (30%), and feelings of inadequacy due to physical appearance (28%). Twentyfour percent of the subjects answered that they had tried to resolve their various sexual problems with their partner; in 28% the illness had no negative effects on the relationship and in 12% it even reinforced the relationship. Sexual habits seem to have been compromised less by the illness than by personal relationships: negative effects were due to hypochondria in 22% and a perception of inadequate health in 14%. Sexual habits were not modified in 34% of cases. In 12% of cases the quality of sexual activity was considered to have improved.
With respect to the problem of information received and the opportunity to talk about sexual disorders which may arise before and during the various treatments, it emerged that 10% of the subjects were able to speak to doctors and 8% with psychologists while 62% of the women spoke to their partner, 24% with friends or relatives and 10% with other women with the same disease.
In this sample we found no statistically significant correlation between the presence of sexual dysfunctions and other variables (age, marital status, qualifications, work activity, type of surgery, use of preventative medicine). This absence of correlation is probably due to the small sample size and its general homogeneity, and therefore the data cannot be used to make generalizations about larger samples.
Discussion
We were not able to compare the data from this study regarding sexual problems with those of other groups (normal population or samples of subjects with chronic disease) since to date no epidemiological studies of sexual behaviour and distribution of sexual dysfunctions in the normal population have been performed in Italy. Nor was it possible to make a comparison between the data obtained from this study and that which had emerged from research carried out in other countries because of cultural, social, economic and moral variables which enormously condition sexual behaviour. Furthermore, there is no common consensus in the medical field of normal or pathological sexual behaviour and different studies assess sexual behaviour using different parameters and definitions and are therefore not comparable [16] . The most significant studies at an international level describe 'reporting' of sexual problems without in most instances (59%-80%) indicating the detection or diagnostic criteria [17] .
The DSM-IV model was consulted by the authors when compiling the questionnaire, as it is an internationally recognised tool used in psychiatric diagnosis and because no other valid model exists in sexology for the evaluation of sexual problems. However, it is not justifiable to make psychiatric diagnoses of sexual dysfunctions which may be experienced by breast cancer patients because the clinical and medical implications of various therapies (especially chemotherapy and hormone therapy) are not yet known [18, 19] . The numerous studies of sexual behaviour in cancer patients are essentially concerned with disturbances of the genitalia (testicle, prostate, vagina, uterus). Often reported are general increases in sexual disturbance which are concomitant with the onset of cancer and its subsequent treatment, without specification of how the disturbance has been defined and assessed or which 'normal' reference is used as a comparison.
We do not aim in this study to diagnose sexual dysfunction but rather more accurately to assess in treated breast cancer patients the subjective disturbance of sexual dysfunction that often is not expressed and that contributes to further lowering the quality of life (in the broadest sense of the term).
The data obtained from this study must be interpreted with caution since they reflect the limited methodology with which the research was conducted. The sample seems to be too small and not representative enough to allow us to extrapolate the data for a larger population. The questionnaire allows a subjective interpretation of both sexual and relationship problems but does not allow us to make a real clinical or epidemiological diagnosis. However, the study does sufficiently address a problem that needs to be investigated in greater depth.
The reported data show that the onset of sexual dysfunctions in concomitance with and after treatment of breast cancer is frequent and that such dysfunctions noticeably compromise the quality of sex life.
Although it is not possible to make distinctions, it appears that the most numerous dysfunctions are those which originate easily from compromises in psychological state (absence and reduction of desire, frigidity) while the fewest dysfunctions were of an organic or functional nature (vaginismus, dyspareunia). These disturbances, even though they noticeably reduce the quality of sex life, do not compromise it completely, as the majority of subjects remain sexually active. Personal relationships are also adequately maintained and partners appear to be very helpful to patients in their adaptation to the illness and treatment, while the physician and health workers play a much less significant role in this type of support.
The doctor should pay more attention to discussing sexual dysfunctions with the patient as part of the side effects experienced during the programme of treatment for breast cancer. Since it is considered an indication of health and vitality, it is important that adequate sexual activity be maintained whenever possible. It helps combat the image of the disease as debilitating and favours adaptation to the illness while preserving the residual health of the patient. 
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